CIK 0001745648
- Non-accelerated filer
- Smaller reporting company
- Emerging growth company
Apnimed, Inc.
Sign in to watch- Ticker
- APMD
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 821910611
- Phone
- +1 617-500-8880
- Business address
- 39 JOHN F. KENNEDY STREET, 4TH FLR., CAMBRIDGE, MA, 02138
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2036-08-03 | Kelly Michael B Chief Financial Officer | Returned to the company · Stock Option (Right to Buy) | −31,434 | 0 | ||
| 2036-08-03 | Kelly Michael B Chief Financial Officer | Grant or award · Stock Option (Right to Buy) | +31,434 | 31,434 | ||
| 2036-07-30 | Kelly Michael B Chief Financial Officer | Grant or award · Stock Option (Right to Buy) | +31,434 | 31,434 | ||
| 2026-08-03 | Kelly Michael B Chief Financial Officer | Returned to the company · Stock Option (Right to Buy) | −333,580 | 0 | ||
| 2026-08-03 | Kelly Michael B Chief Financial Officer | Grant or award · Stock Option (Right to Buy) | +333,580 | 333,580 |
Page 1 of 1 · 5 trades